ULK
Mammalian Unc-51–like kinases 1 and 2 (ULK1 and ULK2) belong to the ULK/Atg1 family of serine/threonine kinases, which are conserved from yeast to mammals. Atg1 interacts with at least eight other proteins, some of which participate in autophagy (i.e., Atg17–Atg29–Atg31), and others exclusively participate in the Cvt pathway (i.e., Atg11–Atg20–Atg24 and Vac8). The activation of yeast Atg1 is linked to metabolic status via posttranslational modifications by energy sensors, including TORC1 and PKA. For example, phosphorylation of Atg13 by TORC1 reduces its binding affinity for Atg1 and Atg17, thereby limiting autophagy induction under nutrient-replete conditions. Mammalian ULK1 and ATG13 are phosphorylated by mTOR under normal growth conditions and are rapidly dephosphorylated in response to amino acid deprivation, thus activating ULK/ATG1 activity. Glucose and amino acid starvation also activate AMPK, leading to the phosphorylation of ULK1 and ULK2 at multiple sites within their unstructured serine–proline-rich domain. Thus, mTOR and AMPK cooperatively sense the metabolic cues and relay them to the ULK/ATG1 complex. ULK1 is also activated by the GSK3–TIP60-signaling axis upon growth factor deprivation. Alterations in ULK/Atg1 expression and autophagy-related functions have been implicated in the prognosis of some cancers.
References
1.Bo Wang,et al. Curr Opin Cell Biol. 2017 Apr; 45: 47–54.
References
1.Bo Wang,et al. Curr Opin Cell Biol. 2017 Apr; 45: 47–54.
Autophagy
ULK
-
ULK-100
catalog no : M16933
cas no: ——
ULK-100 (ULK100) is a potent and selective ULK1 inhibitor with in vitro IC50 of 1.6 nM, inhibits ULK2 with IC50 of 2.6 nM. -
SR-19871
catalog no : M16920
cas no: ——
A novel potent ULK1 inhibitor with IC50 of 11 nM. -
SR-20295
catalog no : M13457
cas no: 2166091-48-9
SR-20295 (SR20295) is a novel potent ULK1 inhibitor with IC50 of 45 nM. -
BL-918
catalog no : M13336
cas no: 2101517-69-3
BL-918 is a small molecule activator of ULK1 with EC50 of 24 nM (243% kinase activity at 100 nM). -
LYN-1604
catalog no : M13261
cas no: 2088939-99-3
LYN-1604 is a potential ULK1 agonist (enzymatic activity=195.7% at 100 nM and IC50=1.66 uM against MDA-MB-231 cells).